Giulia Mazzaschi

1.5k total citations
54 papers, 634 citations indexed

About

Giulia Mazzaschi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Giulia Mazzaschi has authored 54 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Giulia Mazzaschi's work include Cancer Immunotherapy and Biomarkers (23 papers), Lung Cancer Treatments and Mutations (12 papers) and Radiomics and Machine Learning in Medical Imaging (11 papers). Giulia Mazzaschi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (23 papers), Lung Cancer Treatments and Mutations (12 papers) and Radiomics and Machine Learning in Medical Imaging (11 papers). Giulia Mazzaschi collaborates with scholars based in Italy, United States and Netherlands. Giulia Mazzaschi's co-authors include Marcello Tiseo, Federico Quaini, Alessandro Leonetti, Elisa Giovannetti, Christian Rolfo, Yehuda G. Assaraf, Sebastiano Buti, Paola Bordi, Roberta Minari and Gabriele Missale and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Giulia Mazzaschi

50 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Mazzaschi Italy 11 444 254 166 130 96 54 634
Andy Karabajakian France 9 537 1.2× 246 1.0× 138 0.8× 103 0.8× 84 0.9× 19 684
Muhammad Zubair Afzal United States 11 383 0.9× 175 0.7× 143 0.9× 166 1.3× 98 1.0× 31 543
Beung‐Chul Ahn South Korea 12 497 1.1× 366 1.4× 106 0.6× 106 0.8× 81 0.8× 38 621
Angel Qin United States 12 343 0.8× 201 0.8× 94 0.6× 178 1.4× 122 1.3× 33 561
Guoqiang Wang China 9 455 1.0× 227 0.9× 101 0.6× 89 0.7× 88 0.9× 24 561
Zhuoran Yao China 8 660 1.5× 220 0.9× 254 1.5× 133 1.0× 66 0.7× 19 817
Petros Fessas United Kingdom 8 341 0.8× 133 0.5× 141 0.8× 91 0.7× 64 0.7× 14 529
Audrey Hennequin France 11 410 0.9× 154 0.6× 195 1.2× 106 0.8× 81 0.8× 34 561
R. Houston Thompson United Kingdom 2 520 1.2× 207 0.8× 312 1.9× 92 0.7× 71 0.7× 4 637

Countries citing papers authored by Giulia Mazzaschi

Since Specialization
Citations

This map shows the geographic impact of Giulia Mazzaschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Mazzaschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Mazzaschi more than expected).

Fields of papers citing papers by Giulia Mazzaschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Mazzaschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Mazzaschi. The network helps show where Giulia Mazzaschi may publish in the future.

Co-authorship network of co-authors of Giulia Mazzaschi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Mazzaschi. A scholar is included among the top collaborators of Giulia Mazzaschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Mazzaschi. Giulia Mazzaschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pecci, Federica, et al.. (2025). 358P: Baseline circulating immunophenotype may predict irAEs onset in NSCLC patients treated with ICIs. Journal of Thoracic Oncology. 20(3). S213–S213. 1 indexed citations
2.
Rebuzzi, Sara Elena, Giulia Mazzaschi, Federica Pecci, et al.. (2025). The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab. Cancer Treatment and Research Communications. 43. 100927–100927.
3.
Mazzaschi, Giulia, M.A. Manini, Roberta Minari, et al.. (2025). EP.11.05 Prognostic Value of Hb/RDW and Its Correlation With Immune-Inflammatory Profile in NSCLC Receiving First-Line Immunotherapy. Journal of Thoracic Oncology. 20(10). S784–S784.
4.
Manini, M.A., Federica Pecci, Giulia Mazzaschi, et al.. (2025). 362P: LIPI score in advanced NSCLC treated with ICIs: Prognostic impact and blood immune-inflammatory correlations. Journal of Thoracic Oncology. 20(3). S215–S215.
5.
Leonetti, Alessandro, Roberta Minari, Francesco Bonatti, et al.. (2024). Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC. Clinical Lung Cancer. 25(8). e436–e445.e9. 2 indexed citations
6.
Mazzaschi, Giulia, et al.. (2023). Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario. Technology in Cancer Research & Treatment. 22. 2223901641–2223901641. 5 indexed citations
7.
Santoni, Matteo, Javier Molina‐Cerrillo, Giorgio Santoni, et al.. (2023). Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences. Cancers. 15(2). 408–408. 8 indexed citations
8.
9.
Leonetti, Alessandro, Giulia Mazzaschi, Fabiana Perrone, et al.. (2023). Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors. BMJ Supportive & Palliative Care. 14(e2). e2003–e2010. 1 indexed citations
10.
Mazzaschi, Giulia, Costanza Lagrasta, Caterina Frati, et al.. (2022). Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma. Cancers. 14(13). 3249–3249. 3 indexed citations
11.
Catalano, Martina, Ugo De Giorgi, Marco Maruzzo, et al.. (2022). Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma. Biomedicines. 10(10). 2444–2444. 3 indexed citations
12.
Mazzaschi, Giulia, Federico Quaini, & Sebastiano Buti. (2022). Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review. SHILAP Revista de lepidopterología. 4. 100146–100146. 3 indexed citations
13.
Buti, Sebastiano, Melissa Bersanelli, Giulia Mazzaschi, et al.. (2021). Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis. Immunotherapy. 14(2). 145–153. 3 indexed citations
14.
Mazzaschi, Giulia, Chiara Tommasi, Elisabetta Pietri, et al.. (2021). Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report. SHILAP Revista de lepidopterología. 9(3). 1334–1338. 10 indexed citations
15.
Minari, Roberta, Francesco Bonatti, Giulia Mazzaschi, et al.. (2021). PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Tumori Journal. 108(1). 47–55. 9 indexed citations
16.
Mazzaschi, Giulia, Gianluca Milanese, Denise Madeddu, et al.. (2021). Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients. Tumori Journal. 108(1). 86–92. 6 indexed citations
17.
Bersanelli, Melissa, Giulia Mazzaschi, Patrizia Giannatempo, et al.. (2021). Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group). Immunotherapy. 14(2). 107–114. 2 indexed citations
18.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 31. 105781–105781. 5 indexed citations
19.
Bocchialini, Giovanni, Costanza Lagrasta, Denise Madeddu, et al.. (2020). Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery. 58(3). 619–628. 18 indexed citations
20.
Mazzaschi, Giulia, Roberta Minari, Alessandra Zecca, et al.. (2020). Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients. Lung Cancer. 148. 1–11. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andy Karabajakian Breakdown of academic impact, for papers by Muhammad Zubair Afzal Breakdown of academic impact, for papers by Beung‐Chul Ahn Breakdown of academic impact, for papers by Angel Qin Breakdown of academic impact, for papers by Guoqiang Wang Breakdown of academic impact, for papers by Zhuoran Yao Breakdown of academic impact, for papers by Petros Fessas Breakdown of academic impact, for papers by Audrey Hennequin Breakdown of academic impact, for papers by R. Houston Thompson
Rankless by CCL
2026